NDC 0002-1445

TALTZ

Ixekizumab

TALTZ is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Ixekizumab.

Product ID0002-1445_03dc46ee-3620-47a2-9293-90aa3e6c62cf
NDC0002-1445
Product TypeHuman Prescription Drug
Proprietary NameTALTZ
Generic NameIxekizumab
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2016-03-22
Marketing CategoryBLA / BLA
Application NumberBLA125521
Labeler NameEli Lilly and Company
Substance NameIXEKIZUMAB
Active Ingredient Strength80 mg/mL
Pharm ClassesInterleukin-17A Antagonist [EPC],Interleukin-17A Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0002-1445-09

3 SYRINGE in 1 CARTON (0002-1445-09) > 1 mL in 1 SYRINGE (0002-1445-01)
Marketing Start Date2016-03-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0002-1445-61 [00002144561]

TALTZ INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125521
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-04-19

NDC 0002-1445-11 [00002144511]

TALTZ INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125521
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-03-22

NDC 0002-1445-01 [00002144501]

TALTZ INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125521
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-03-22

NDC 0002-1445-09 [00002144509]

TALTZ INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125521
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-03-22

NDC 0002-1445-27 [00002144527]

TALTZ INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA125521
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-03-22

Drug Details

Active Ingredients

IngredientStrength
IXEKIZUMAB80 mg/mL

OpenFDA Data

SPL SET ID:ac96658a-d7dc-4c7c-8928-2adcdf4318b2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1745108
  • 1745103
  • 1745112
  • 1745114
  • Pharmacological Class

    • Interleukin-17A Antagonist [EPC]
    • Interleukin-17A Antagonists [MoA]

    NDC Crossover Matching brand name "TALTZ" or generic name "Ixekizumab"

    NDCBrand NameGeneric Name
    0002-1445TALTZixekizumab
    0002-7724TALTZixekizumab

    Trademark Results [TALTZ]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TALTZ
    TALTZ
    87943085 5892274 Live/Registered
    Eli Lilly and Company
    2018-05-31
    TALTZ
    TALTZ
    86422198 not registered Dead/Abandoned
    Eli Lilly and Company
    2014-10-13
    TALTZ
    TALTZ
    86018989 5205206 Live/Registered
    Eli Lilly and Company
    2013-07-24
    TALTZ
    TALTZ
    85476614 4836996 Live/Registered
    Eli Lilly and Company
    2011-11-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.